Showing 3,481 - 3,500 results of 18,439 for search 'significantly ((((((less decrease) OR (largest decrease))) OR (mean decrease))) OR (a decrease))', query time: 0.65s Refine Results
  1. 3481

    Image 3_Characterization of serum metabolome and respiratory microbiota in children with influenza A virus infection.jpeg by Xinyi Shi (3133611)

    Published 2025
    “…<p>The risk of children being infected with Influenza A virus (IAV) is high, and if not treated promptly, it can lead to serious illness. …”
  2. 3482

    Image 1_Characterization of serum metabolome and respiratory microbiota in children with influenza A virus infection.jpeg by Xinyi Shi (3133611)

    Published 2025
    “…<p>The risk of children being infected with Influenza A virus (IAV) is high, and if not treated promptly, it can lead to serious illness. …”
  3. 3483

    S1 Graphical abstract - by Aman Goyal (19231397)

    Published 2025
    “…</p><p>Conclusions</p><p>Our analysis showed a significant decrease in mortality from paroxysmal tachycardia since 1999, although there has been a slight increase in recent years. …”
  4. 3484

    3‑Furoic Acid from Sea-Derived Aspergillus luchuensis Hy‑6 as a Valuable Lead Compound against Plant-Parasitic Nematodes in Cucumber by Linsong Wang (6447482)

    Published 2025
    “…Root-knot nematodes pose a significant threat to crop growth and yield, thereby impacting global food security. …”
  5. 3485

    Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  6. 3486

    Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  7. 3487
  8. 3488
  9. 3489
  10. 3490
  11. 3491

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  12. 3492

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  13. 3493

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  14. 3494

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  15. 3495

    Table 2_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.docx by Ji Zhou (481629)

    Published 2025
    “…RQR significantly increased on day 4 in the non-survival group (median 5.285), and decreased in the survival group (median 0.1864). …”
  16. 3496

    Image 1_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.tif by Ji Zhou (481629)

    Published 2025
    “…RQR significantly increased on day 4 in the non-survival group (median 5.285), and decreased in the survival group (median 0.1864). …”
  17. 3497

    Table 3_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.docx by Ji Zhou (481629)

    Published 2025
    “…RQR significantly increased on day 4 in the non-survival group (median 5.285), and decreased in the survival group (median 0.1864). …”
  18. 3498

    Table 1_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.doc by Ji Zhou (481629)

    Published 2025
    “…RQR significantly increased on day 4 in the non-survival group (median 5.285), and decreased in the survival group (median 0.1864). …”
  19. 3499
  20. 3500